Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May;30(5):461-8.
doi: 10.1007/s40263-016-0330-y.

Tasimelteon: A Review in Non-24-Hour Sleep-Wake Disorder in Totally Blind Individuals

Gillian M Keating  1
Affiliations
Review

Tasimelteon: A Review in Non-24-Hour Sleep-Wake Disorder in Totally Blind Individuals

Gillian M Keating. CNS Drugs. 2016 May.

Abstract

Tasimelteon (Hetlioz(®)) is a dual melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) (free-running disorder). In two randomized, double-masked, multicentre, phase III trials, totally blind individuals with Non-24 who received oral tasimelteon 20 mg once nightly were significantly more likely than those receiving placebo to entrain the circadian pacemaker (the SET trial) and maintain entrainment (the RESET trial). Sleep/wake parameters and functioning were also improved with tasimelteon. Oral tasimelteon was generally well tolerated in totally blind patients with Non-24. In conclusion, tasimelteon is a useful drug for the treatment of Non-24 in totally blind individuals.

PubMed Disclaimer

References

    1. Lancet. 2015 Oct 31;386(10005):1713 - PubMed
    1. Chronobiol Int. 2012 Oct;29(8):1072-7 - PubMed
    1. Science. 1999 Jun 25;284(5423):2177-81 - PubMed
    1. Sleep. 2007 Nov;30(11):1460-83 - PubMed
    1. J Biol Rhythms. 2008 Aug;23(4):374-6 - PubMed

MeSH terms

LinkOut - more resources